Skip to main content

Clinical trial IJB_2674

A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Including FGFR2 Translocations Who Failed Previous Therapy

Cancers
Organ Liver
Trial status Trial closed
Trial type
Interventional with experimental drug
Phase Trial phase 2
Academic trial Non
Sponsor Incyte Corporate
EudraCT Identifier 2016-002422-36
ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT02924376
Inclusion criteria second line metastatic
Last update